特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
953517

肺癌スクリーニングソフトウェアの世界市場:業界動向と予測 (~2027年)

Global Lung Cancer Screening Software Market - Industry Trends and Forecast to 2027

出版日: | 発行: Data Bridge Market Research Private Limited | ページ情報: 英文 488 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.45円
肺癌スクリーニングソフトウェアの世界市場:業界動向と予測 (~2027年)
出版日: 2020年07月01日
発行: Data Bridge Market Research Private Limited
ページ情報: 英文 488 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の肺癌スクリーニングソフトウェア市場規模は、2020年から2027年の予測期間中、19.2%のCAGRで推移すると見込まれています。

当レポートでは、世界の肺癌スクリーニングソフトウェア市場について調査し、市場の概要とダイナミクス、各セグメント・地域別による市場規模の分析と予測、および主要企業のプロファイルなどを提供しています。

第1章 イントロダクション

第2章 市場セグメンテーション

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 規制&医療費償還

第6章 市場におけるCOVID-19パンデミックの影響

  • 価格へのの影響
  • 需要への影響
  • サプライチェーンへの影響
  • 製造業者のための戦略決定
  • 結論

第7章 市場概要

  • 促進要因
    • 世界的な肺がん有病率の増加
    • 早期診断と頻繁なスクリーニングの利点に関する意識の向上
    • 様々な疾患のスクリーニングプログラムを実施するための政府のイニシアチブ
    • 世界的なスクリーニングプログラム数の増加
    • ヘルスケア分野の技術進歩
  • 抑制要因
    • ソフトウェアの可用性に関連する問題
    • 癌診断の技術的な知識を持つ専門家の不足
    • さまざまな地域で癌および癌関連疾患の資金・資源が不足
  • 市場機会
    • 市場参入企業間のコラボレーション、合併、買収の拡大
    • ヘルスケアセグメントへの投資の増加
    • 肺癌スクリーニングソフトウェアに関連する複数の利点
  • 課題
    • スクリーニングソフトウェアおよび関連サービスのコストが高額
    • 肺癌スクリーニングソフトウェアの開発に関連する課題の増加
    • 市場競合の激化

第8章 世界の肺癌スクリーニングソフトウェア市場:提供形態別

  • 概要
  • クラウドベースソリューション
  • オンプレミスソリューション
  • Webベースソリューション

第9章 世界の肺癌スクリーニングソフトウェア市場:製品別

  • 概要
  • 肺癌スクリーニング放射線医学ソリューション
    • クラウドベースソリューション
    • オンプレミスソリューション
    • Webベースソリューション
  • 肺癌スクリーニング患者管理ソフトウェア
  • 結節管理ソフトウェア
  • データ収集・レポーティング
  • 患者コーディネーション・ワークフロー
  • 肺結節コンピューター支援検出
  • 病理学・癌病期分類
  • 統計監査報告
  • スクリーンパック
  • 診察管理
  • 監査ログトラッキング

第10章 世界の肺癌スクリーニングソフトウェア市場:タイプ別

  • 概要
  • コンピュータ支援スクリーニング
    • オンプレミスソリューション
    • Webベースソリューション
    • クラウドベースソリューション
  • 従来型スクリーニング

第11章 世界の肺癌スクリーニングソフトウェア市場:用途別

  • 概要
  • 非小細胞肺がん(NSCLC)
    • オンプレミスソリューション
    • Webベースソリューション
    • クラウドベースソリューション
  • 小細胞肺がん(SCLC)

第12章 世界の肺癌スクリーニングソフトウェア市場:プラットフォーム別

  • 概要
  • スタンドアロン
    • オンプレミスソリューション
    • Webベースソリューション
    • クラウドベースソリューション
  • 統合型

第13章 世界の肺癌スクリーニングソフトウェア市場:購入形態別

  • 概要
  • 組織
  • 個人

第14章 世界の肺癌スクリーニングソフトウェア市場:エンドユーザー別

  • 概要
  • 腫瘍学センター
  • 病院
  • 外来手術センター
  • その他

第15章 世界の肺癌スクリーニングソフトウェア市場:流通チャネル別

  • 概要
  • 直接入札
  • サードパーティのディストリビューター

第16章 世界の肺癌スクリーニングソフトウェア市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • スイス
    • ベルギー
    • フィリピン
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • オーストラリア
    • 韓国
    • インド
    • シンガポール
    • タイ
    • マレーシア
    • インドネシア
    • フィリピン
    • その他アジア太平洋地域
  • 南米
    • ブラジル
    • アルゼンチン
    • 南米
  • 中東とアフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • イスラエル
    • エジプト
    • その他中東・アフリカ

第17章 世界の肺癌スクリーニングソフトウェア市場:企業情勢

  • 企業シェア分析: 世界
  • 企業シェア分析: 北米
  • 企業シェア分析:欧州
  • 企業シェア分析:アジア太平洋

第18章 SWOT分析

第19章 企業プロファイル

  • KONINKLIJKE PHILIPS N.V
  • NUANCE COMMUNICATIONS, INC.
  • SIEMENS HEALTHCARE GMBH
  • LUNGVIEW
  • MEDTRONIC
  • THYNK HEALTH
  • VITAL IMAGES (A SUBSIDIARY OF CANON GROUP COMPANY)
  • MEVIS MEDICAL SOLUTIONS AG
  • HEALTHMYNE
  • VOLPARA SOLUTIONS LIMITED
  • CORELINE SOFT, CO., LTD.
  • EON
  • MYCAREWARE INC
  • OPTELLUM LTD
  • PENRAD TECHNOLOGIES INC.
  • PROVATION MEDICAL, INC.

第20章 アンケート

第21章 関連レポート

図表

LIST OF FIGURES

  • FIGURE 1 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: SEGMENTATION 68
  • FIGURE 2 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: DATA TRIANGULATION 71
  • FIGURE 3 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: DROC ANALYSIS 72
  • FIGURE 4 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 73
  • FIGURE 5 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY RESEARCH ANALYSIS 73
  • FIGURE 6 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: MARKET APPLICATION COVERAGE GRID 75
  • FIGURE 7 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: INTERVIEW DEMOGRAPHICS 77
  • FIGURE 8 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: DBMR MARKET POSITION GRID 78
  • FIGURE 9 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: VENDOR SHARE ANALYSIS 79
  • FIGURE 10 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: SEGMENTATION 83
  • FIGURE 11 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2027 84
  • FIGURE 12 RISING LUNG CANCER SCREENING PROGRAMS AND TECHNOLOGICAL ADVANCEMENT IN THE FIELD OF HEALTHCARE IS EXPECTED TO DRIVE THE GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET IN THE FORECAST PERIOD OF 2020 TO 2027 85
  • FIGURE 13 CLOUD BASED SOLUTIONS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET IN 2020 & 2027 85
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR LUNG CANCER SCREENING SOFTWARE DEVELOPERS IN THE FORECAST PERIOD OF 2020 TO 2027 86
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES OF GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET 91
  • FIGURE 16 LUNG CANCER INCIDENCE AND MORTALITY RATES, 2018 92
  • FIGURE 17 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY MODE OF DELIVERY, 2019 102
  • FIGURE 18 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY MODE OF DELIVERY, 2019-2027 (USD THOUSAND) 103
  • FIGURE 19 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY MODE OF DELIVERY, CAGR (2020-2027) 103
  • FIGURE 20 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY MODE OF DELIVERY, LIFELINE CURVE 104
  • FIGURE 21 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PRODUCT, 2019 109
  • FIGURE 22 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PRODUCT, 2019-2027 (USD THOUSAND) 110
  • FIGURE 23 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PRODUCT, CAGR (2020-2027) 110
  • FIGURE 24 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PRODUCT, LIFELINE CURVE 112
  • FIGURE 25 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY TYPE, 2019 130
  • FIGURE 26 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY TYPE, 2019-2027 (USD THOUSAND) 131
  • FIGURE 27 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY TYPE, CAGR (2020-2027) 131
  • FIGURE 28 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY TYPE, LIFELINE CURVE 132
  • FIGURE 29 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY APPLICATION, 2019 137
  • FIGURE 30 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY APPLICATION, 2019-2027 (USD THOUSAND) 138
  • FIGURE 31 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY APPLICATION, CAGR (2020-2027) 138
  • FIGURE 32 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY APPLICATION, LIFELINE CURVE 139
  • FIGURE 33 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PLATFORM, 2019 145
  • FIGURE 34 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PLATFORM, 2019-2027 (USD THOUSAND) 146
  • FIGURE 35 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PLATFORM, CAGR (2020-2027) 146
  • FIGURE 36 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PLATFORM, LIFELINE CURVE 147
  • FIGURE 37 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PURCHASE MODE, 2019 152
  • FIGURE 38 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PURCHASE MODE, 2019-2027 (USD THOUSAND) 153
  • FIGURE 39 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PURCHASE MODE, CAGR (2020-2027) 153
  • FIGURE 40 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PURCHASE MODE, LIFELINE CURVE 154
  • FIGURE 41 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY END USER, 2019 158
  • FIGURE 42 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY END USER, 2019-2027 (USD THOUSAND) 159
  • FIGURE 43 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY END USER, CAGR (2020-2027) 159
  • FIGURE 44 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY END USER, LIFELINE CURVE 160
  • FIGURE 45 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY DISTRIBUTION CHANNEL, 2019 165
  • FIGURE 46 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD THOUSAND) 166
  • FIGURE 47 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027) 166
  • FIGURE 48 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 167
  • FIGURE 49 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: SNAPSHOT (2019) 171
  • FIGURE 50 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2019) 173
  • FIGURE 51 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2020 & 2027) 173
  • FIGURE 52 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2019 & 2027) 174
  • FIGURE 53 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: BY PRODUCT (2020-2027) 174
  • FIGURE 54 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET: SNAPSHOT (2019) 176
  • FIGURE 55 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2020) 178
  • FIGURE 56 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2019 & 2027) 178
  • FIGURE 57 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2019 & 2027) 179
  • FIGURE 58 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET: BY TYPE (2020-2027) 179
  • FIGURE 59 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: SNAPSHOT (2019) 209
  • FIGURE 60 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2020) 211
  • FIGURE 61 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2019 & 2027) 211
  • FIGURE 62 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2019 & 2027) 212
  • FIGURE 63 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY TYPE (2020-2027) 212
  • FIGURE 64 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: SNAPSHOT (2019) 292
  • FIGURE 65 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2020) 294
  • FIGURE 66 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2019 & 2027) 294
  • FIGURE 67 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2019 & 2027) 295
  • FIGURE 68 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY TYPE (2020-2027) 295
  • FIGURE 69 SOUTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET: SNAPSHOT (2019) 375
  • FIGURE 70 SOUTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2020) 377
  • FIGURE 71 SOUTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2019 & 2027) 377
  • FIGURE 72 SOUTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2019 & 2027) 378
  • FIGURE 73 SOUTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET: BY TYPE (2020-2027) 378
  • FIGURE 74 MIDDLE EAST AND AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: SNAPSHOT (2019) 401
  • FIGURE 75 MIDDLE EAST AND AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2020) 403
  • FIGURE 76 MIDDLE EAST AND AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2019 & 2027) 403
  • FIGURE 77 MIDDLE EAST AND AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2019 & 2027) 404
  • FIGURE 78 MIDDLE EAST AND AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY TYPE (2020-2027) 404
  • FIGURE 79 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY SHARE 2019 (%) 449
  • FIGURE 80 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY SHARE 2019 (%) 450
  • FIGURE 81 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY SHARE 2019 (%) 451
  • FIGURE 82 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY SHARE 2019 (%) 452
目次

Global lung cancer screening software market is projected to register a CAGR of 19.2% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

Global Lung Cancer Screening Software Market, By Mode of Delivery (Cloud Based Solutions, On-premise Solutions, & Web Based Solutions), Type (Computer-Assisted Screening and Traditional Screening), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management & Audit Log Tracking), Application (Non-Small Cell Lung Cancer (NSCLC) & Small Cell Lung Cancer (SCLC), Platform (Standalone, Integrated), Purchase Mode (Institutional & Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers & Others), Distribution Channel (Direct Tenders, Third Party Distributor), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Egypt, Rest of Middle East and Africa)- Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the global lung cancer screening software market are:

Increasing prevalence of lung cancer cases globally

Growing number of screening programs across the globe

Market Players:

The key market players for global lung cancer screening software market are listed below:

Medtronic

PenRad Technologies Inc.

Koninklijke Philips N.V.

Volpara Solutions Limited

Lungview

Siemens Healthcare Private Limited

Thynk Health, Eon

Nuance Communications, Inc.

MeVis Medical Solutions AG

Vital Images (A Subsidiary of Canon Group company)

HealthMyne

Optellum Ltd

Coreline Soft, Co., Ltd.

MyCareWare

ProVation Medical, Inc.

TABLE OF CONTENTS

1 INTRODUCTION 62

  • 1.1 OBJECTIVES OF THE STUDY 62
  • 1.2 MARKET DEFINITION 62
  • 1.3 OVERVIEW OF GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET 62
  • 1.4 LIMITATION 64
  • 1.5 MARKETS COVERED 64

2 MARKET SEGMENTATION 68

  • 2.1 MARKETS COVERED 68
  • 2.2 GEOGRAPHICAL SCOPE 69
  • 2.3 YEARS CONSIDERED FOR THE STUDY 70
  • 2.4 CURRENCY AND PRICING 70
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 71
  • 2.6 MULTIVARIATE MODELLING 74
  • 2.7 MARKET APPLICATION COVERAGE GRID 75
  • 2.8 MODE OF DELIVERY LIFELINE CURVE 76
  • 2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 77
  • 2.10 DBMR MARKET POSITION GRID 78
  • 2.11 VENDOR SHARE ANALYSIS 79
  • 2.12 SECONDARY SOURCES 80
  • 2.13 ASSUMPTIONS 80

3 EXECUTIVE SUMMARY 81

4 PREMIUM INSIGHTS 85

5 REGULATIONS & REIMBURSEMENT 87

6 IMPACT OF COVID-19 PANDEMIC ON THE MARKET 88

  • 6.1 PRICE IMPACT 88
  • 6.2 IMPACT ON DEMAND 88
  • 6.3 IMPACT ON SUPPLY CHAIN 88
  • 6.4 STRATEGIC DECISIONS FOR MANUFACTURERS 89
  • 6.5 CONCLUSION 89

7 MARKET OVERVIEW 90

  • 7.1 DRIVERS 92
    • 7.1.1 INCREASING PREVALENCE OF LUNG CANCER CASES GLOBALLY 92
    • 7.1.2 INCREASING AWARENESS REGARDING THE BENEFITS OF EARLY DIAGNOSIS AND FREQUENT SCREENING 93
    • 7.1.3 GOVERNMENT INITIATIVES UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES 93
    • 7.1.4 GROWING NUMBER OF SCREENING PROGRAMS ACROSS THE GLOBE 94
    • 7.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE 95
  • 7.2 RESTRAINTS 95
    • 7.2.1 ISSUES RELATED WITH THE AVAILABILITY OF SOFTWARE 95
    • 7.2.2 SCARCITY OF TECHNICALLY KNOWLEDGEABLE PROFESSIONALS FOR CANCER DIAGNOSIS 96
    • 7.2.3 LACK OF FUNDING AND OTHER RESOURCES FROM VARIOUS REGIONS FOR CANCER AND ASSOCIATED DISORDERS 96
  • 7.3 OPPORTUNITIES 97
    • 7.3.1 RISING COLLABORATIONS, MERGERS & ACQUISITIONS AMONG THE MARKET PLAYERS 97
    • 7.3.2 INCREASING INVESTMENTS IN HEALTHCARE SEGMENTS 98
    • 7.3.3 MULTIPLE BENEFITS ASSOCIATED WITH LUNG CANCER SCREENING SOFTWARE 99
  • 7.4 CHALLENGES 99
    • 7.4.1 HIGH COST OF SCREENING SOFTWARE AND RELATED SERVICES 99
    • 7.4.2 INCREASING CHALLENGES RELATED TO DEVELOPMENT OF LUNG CANCER SCREENING SOFTWARE 100
    • 7.4.3 INCREASING COMPETITION IN THE MARKET 100

8 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY 101

  • 8.1 OVERVIEW 102
  • 8.2 CLOUD BASED SOLUTIONS 105
  • 8.3 ON-PREMISE SOLUTIONS 106
  • 8.4 WEB BASED SOLUTIONS 106

9 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT 108

  • 9.1 OVERVIEW 109
  • 9.2 LUNG CANCER SCREENING RADIOLOGY SOLUTION 113
    • 9.2.1 ON-PREMISE SOLUTIONS 115
    • 9.2.2 WEB BASED SOLUTIONS 115
    • 9.2.3 CLOUD BASED SOLUTIONS 115
  • 9.3 LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE 115
    • 9.3.1 ON-PREMISE SOLUTIONS 116
    • 9.3.2 WEB BASED SOLUTIONS 116
    • 9.3.3 CLOUD BASED SOLUTIONS 116
  • 9.4 NODULE MANAGEMENT SOFTWARE 116
    • 9.4.1 ON-PREMISE SOLUTIONS 117
    • 9.4.2 WEB BASED SOLUTIONS 117
    • 9.4.3 CLOUD BASED SOLUTIONS 117

  • 9.5 DATA COLLECTION AND REPORTING 118
    • 9.5.1 ON-PREMISE SOLUTIONS 119
    • 9.5.2 WEB BASED SOLUTIONS 119
    • 9.5.3 CLOUD BASED SOLUTIONS 119
  • 9.6 PATIENT COORDINATION AND WORKFLOW 119
    • 9.6.1 ON-PREMISE SOLUTIONS 120
    • 9.6.2 WEB BASED SOLUTIONS 120
    • 9.6.3 CLOUD BASED SOLUTIONS 120
  • 9.7 LUNG NODULE COMPUTER AIDED DETECTION 120
    • 9.7.1 ON-PREMISE SOLUTIONS 121
    • 9.7.2 WEB BASED SOLUTIONS 121
    • 9.7.3 CLOUD BASED SOLUTIONS 121
  • 9.8 PATHOLOGY AND CANCER STAGING 122
    • 9.8.1 ON-PREMISE SOLUTIONS 123
    • 9.8.2 WEB BASED SOLUTIONS 123
    • 9.8.3 CLOUD BASED SOLUTIONS 123
  • 9.9 STATISTICAL AUDIT REPORTING 123
    • 9.9.1 ON-PREMISE SOLUTIONS 124
    • 9.9.2 WEB BASED SOLUTIONS 124
    • 9.9.3 CLOUD BASED SOLUTIONS 124
  • 9.10 SCREENING PACS 124
    • 9.10.1 ON-PREMISE SOLUTIONS 125
    • 9.10.2 WEB BASED SOLUTIONS 125
    • 9.10.3 CLOUD BASED SOLUTIONS 125
  • 9.11 PRACTICE MANAGEMENT 126
    • 9.11.1 ON-PREMISE SOLUTIONS 127
    • 9.11.2 WEB BASED SOLUTIONS 127
    • 9.11.3 CLOUD BASED SOLUTIONS 127
  • 9.12 AUDIT LOG TRACKING 127
    • 9.12.1 ON-PREMISE SOLUTIONS 128
    • 9.12.2 WEB BASED SOLUTIONS 128
    • 9.12.3 CLOUD BASED SOLUTIONS 128

10 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE 129

  • 10.1 OVERVIEW 130
  • 10.2 COMPUTER-ASSISTED SCREENING 132
    • 10.2.1 ON-PREMISE SOLUTIONS 133
    • 10.2.2 WEB BASED SOLUTIONS 133
    • 10.2.3 CLOUD BASED SOLUTIONS 134

  • 10.3 TRADITIONAL SCREENING 134
    • 10.3.1 ON-PREMISE SOLUTIONS 135
    • 10.3.2 WEB BASED SOLUTIONS 135
    • 10.3.3 CLOUD BASED SOLUTIONS 135

11 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION 136

  • 11.1 OVERVIEW 137
  • 11.2 NON-SMALL CELL LUNG CANCER (NSCLC) 139
    • 11.2.1 ON-PREMISE SOLUTIONS 140
    • 11.2.2 WEB BASED SOLUTIONS 140
    • 11.2.3 CLOUD BASED SOLUTIONS 140
  • 11.3 SMALL CELL LUNG CANCER (SCLC) 142
    • 11.3.1 ON-PREMISE SOLUTIONS 143
    • 11.3.2 WEB BASED SOLUTIONS 143
    • 11.3.3 CLOUD BASED SOLUTIONS 143

12 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM 144

  • 12.1 OVERVIEW 145
  • 12.2 STANDALONE 147
    • 12.2.1 ON-PREMISE SOLUTIONS 149
    • 12.2.2 WEB BASED SOLUTIONS 149
    • 12.2.3 CLOUD BASED SOLUTIONS 149
  • 12.3 INTEGRATED 149
    • 12.3.1 ON-PREMISE SOLUTIONS 150
    • 12.3.2 WEB BASED SOLUTIONS 150
    • 12.3.3 CLOUD BASED SOLUTIONS 150

13 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE 151

  • 13.1 OVERVIEW 152
  • 13.2 INSTITUTIONAL 154
  • 13.3 INDIVIDUAL 155

14 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER 157

  • 14.1 OVERVIEW 158
  • 14.2 ONCOLOGY CENTERS 160
  • 14.3 HOSPITALS 161
  • 14.4 AMBULATORY SURGICAL CENTERS 162
  • 14.5 OTHERS 163

15 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL 164

  • 15.1 OVERVIEW 165
  • 15.2 DIRECT TENDERS 167
  • 15.3 THIRD PARTY DISTRIBUTOR 168

16 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY GEOGRAPHY 169

  • 16.1 OVERVIEW 170
  • 16.2 NORTH AMERICA 176
    • 16.2.1 U.S. 188
    • 16.2.2 CANADA 195
    • 16.2.3 MEXICO 202
  • 16.3 EUROPE 209
    • 16.3.1 GERMANY 221
    • 16.3.2 FRANCE 228
    • 16.3.3 U.K 235
    • 16.3.4 ITALY 242
    • 16.3.5 SPAIN 249
    • 16.3.6 NETHERLANDS 256
    • 16.3.7 RUSSIA 263
    • 16.3.8 SWITZERLAND 270
    • 16.3.9 BELGIUM 277
    • 16.3.10 PHILIPPINES 284
    • 16.3.11 REST OF EUROPE 291
  • 16.4 ASIA-PACIFIC 292
    • 16.4.1 JAPAN 304
    • 16.4.2 CHINA 311
    • 16.4.3 AUSTRALIA 318
    • 16.4.4 SOUTH KOREA 325
    • 16.4.5 INDIA 332
    • 16.4.6 SINGAPORE 339
    • 16.4.7 THAILAND 346
    • 16.4.8 MALAYSIA 353
    • 16.4.9 INDONESIA 360
    • 16.4.10 PHILIPPINES 367
    • 16.4.11 REST OF ASIA-PACIFIC 374
  • 16.5 SOUTH AMERICA 375
    • 16.5.1 BRAZIL 386
    • 16.5.2 ARGENTINA 393
    • 16.5.3 REST OF SOUTH AMERICA 400
  • 16.6 MIDDLE EAST AND AFRICA 401
    • 16.6.1 SAUDI ARABIA 413
    • 16.6.2 SOUTH AFRICA 420
    • 16.6.3 UAE 427
    • 16.6.4 ISRAEL 434
    • 16.6.5 EGYPT 441
    • 16.6.6 REST OF MIDDLE EAST AND AFRICA 448

17 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, COMPANY LANDSCAPE 449

  • 17.1 COMPANY SHARE ANALYSIS: GLOBAL 449
  • 17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 450
  • 17.3 COMPANY SHARE ANALYSIS: EUROPE 451
  • 17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 452

18 SWOT ANALYSIS 453

19 COMPANY PROFILES 454

  • 19.1 KONINKLIJKE PHILIPS N.V 454
    • 19.1.1 COMPANY SNAPSHOT 454
    • 19.1.2 REVENUE ANALYSIS 454
    • 19.1.3 COMPANY SHARE ANALYSIS 455
    • 19.1.4 PRODUCT PORTFOLIO 456
    • 19.1.5 RECENT DEVELOPMENTS 456
  • 19.2 NUANCE COMMUNICATIONS, INC. 457
    • 19.2.1 COMPANY SNAPSHOT 457
    • 19.2.2 REVENUE ANALYSIS 457
    • 19.2.3 COMPANY SHARE ANALYSIS 458
    • 19.2.4 PRODUCT PORTFOLIO 458
    • 19.2.5 RECENT DEVELOPMENTS 459
  • 19.3 SIEMENS HEALTHCARE GMBH 460
    • 19.3.1 COMPANY SNAPSHOT 460
    • 19.3.2 REVENUE ANALYSIS 461
    • 19.3.3 COMPANY SHARE ANALYSIS 461
    • 19.3.4 PRODUCT PORTFOLIO 462
    • 19.3.5 RECENT DEVELOPMENTS 462
  • 19.4 LUNGVIEW 464
    • 19.4.1 COMPANY SNAPSHOT 464
    • 19.4.2 COMPANY SHARE ANALYSIS 464
    • 19.4.3 SOLUTION PORTFOLIO 465
    • 19.4.4 RECENT DEVELOPMENT 465
  • 19.5 MEDTRONIC 466
    • 19.5.1 COMPANY SNAPSHOT 466
    • 19.5.2 REVENUE ANALYSIS 466
    • 19.5.3 COMPANY SHARE ANALYSIS 467
    • 19.5.4 PRODUCT PORTFOLIO 467
    • 19.5.5 RECENT DEVELOPMENTS 468
  • 19.6 THYNK HEALTH 469
    • 19.6.1 COMPANY SNAPSHOT 469
    • 19.6.2 PRODUCT PORTFOLIO 469
    • 19.6.3 RECENT DEVELOPMENTS 469
  • 19.7 VITAL IMAGES (A SUBSIDIARY OF CANON GROUP COMPANY) 470
    • 19.7.1 COMPANY SNAPSHOT 470
    • 19.7.2 PRODUCT PORTFOLIO 470
    • 19.7.3 RECENT DEVELOPMENTS 470
  • 19.8 MEVIS MEDICAL SOLUTIONS AG 471
    • 19.8.1 COMPANY SNAPSHOT 471
    • 19.8.2 REVENUE ANALYSIS 471
    • 19.8.3 PRODUCT PORTFOLIO 472
    • 19.8.4 RECENT DEVELOPMENTS 472
  • 19.9 HEALTHMYNE 473
    • 19.9.1 COMPANY SNAPSHOT 473
    • 19.9.2 SOLUTION PORTFOLIO 473
    • 19.9.3 RECENT DEVELOPMENTS 474
  • 19.10 VOLPARA SOLUTIONS LIMITED 475
    • 19.10.1 COMPANY SNAPSHOT 475
    • 19.10.2 REVENUE ANALYSIS 475
    • 19.10.3 PRODUCT PORTFOLIO 475
    • 19.10.4 RECENT DEVELOPMENTS 476
  • 19.11 CORELINE SOFT, CO., LTD. 477
    • 19.11.1 COMPANY SNAPSHOT 477
    • 19.11.2 SOLUTION PORTFOLIO 477
    • 19.11.3 RECENT DEVELOPMENTS 478
  • 19.12 EON 479
    • 19.12.1 COMPANY SNAPSHOT 479
    • 19.12.2 SOLUTION PORTFOLIO 479
    • 19.12.3 RECENT DEVELOPMENT 479
  • 19.13 MYCAREWARE INC 480
    • 19.13.1 COMPANY SNAPSHOT 480
    • 19.13.2 PRODUCT PORTFOLIO 480
    • 19.13.3 RECENT DEVELOPMENT 480
  • 19.14 OPTELLUM LTD 481
    • 19.14.1 COMPANY SNAPSHOT 481
    • 19.14.2 PRODUCT PORTFOLIO 481
    • 19.14.3 RECENT DEVELOPMENTS 481
  • 19.15 PENRAD TECHNOLOGIES INC. 482
    • 19.15.1 COMPANY SNAPSHOT 482
    • 19.15.2 SOLUTION PORTFOLIO 482
    • 19.15.3 RECENT DEVELOPMENT 482
  • 19.16 PROVATION MEDICAL, INC. 483
    • 19.16.1 COMPANY SNAPSHOT 483
    • 19.16.2 SOLUTION PORTFOLIO 483
    • 19.16.3 RECENT DEVELOPMENTS 484

20 QUESTIONNAIRE 485

21 RELATED REPORTS 488

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.